LITS
Price:
$1.75
Market Cap:
$64.37M
Lite Strategy, Inc. a clinical-stage pharmaceutical company, focuses on the development of novel and differentiated therapies for the treatment of cancer. The company was formerly known as MEI Pharma, Inc. and changed its name to Lite Strategy, Inc. in September 2025. Lite Strategy, Inc. was incorporated in 2000 and is based in San Diego, California.
Industry
Biotechnology
IPO Date
2003-12-18
Stock Exchange
NASDAQ
Ticker
LITS
According to Lite Strategy, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 54.26M. This represents a change of 142.39% compared to the average of 22.39M of the last 4 quarters.
The mean historical Enterprise Value of Lite Strategy, Inc. over the last ten years is 22.40M. The current 54.26M Enterprise Value has changed 24.12% with respect to the historical average. Over the past ten years (40 quarters), LITS's Enterprise Value was at its highest in in the September 2025 quarter at 61.22M. The Enterprise Value was at its lowest in in the December 2024 quarter at 6.44M.
Average
22.40M
Median
25.24M
Minimum
12.17M
Maximum
26.48M
Discovering the peaks and valleys of Lite Strategy, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 17.69%
Maximum Annual Enterprise Value = 26.48M
Minimum Annual Increase = -54.03%
Minimum Annual Enterprise Value = 12.17M
| Year | Enterprise Value | Change |
|---|---|---|
| 2025 | 12.17M | -54.03% |
| 2024 | 26.48M | 1.82% |
| 2023 | 26.01M | 17.69% |
| 2022 | 22.10M | -12.46% |
The current Enterprise Value of Lite Strategy, Inc. (LITS) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
21.55M
5-year avg
22.40M
10-year avg
22.40M
Lite Strategy, Inc.’s Enterprise Value is greater than TScan Therapeutics, Inc. (-43127305.00), greater than Adicet Bio, Inc. (26.86M), greater than Immunic, Inc. (32.92M), greater than PMV Pharmaceuticals, Inc. (25.00M), less than Relmada Therapeutics, Inc. (291.98M), greater than Nutriband Inc. (49.70M), greater than Acrivon Therapeutics, Inc. Common Stock (43.63M), greater than Werewolf Therapeutics, Inc. (-8613546.00), greater than XBiotech Inc. (-70842795.00), greater than IO Biotech, Inc. (19.58M),
| Company | Enterprise Value | Market cap |
|---|---|---|
| -43127305.00 | $61.86M | |
| 26.86M | $46.22M | |
| 32.92M | $67.93M | |
| 25.00M | $68.11M | |
| 291.98M | $293.33M | |
| 49.70M | $56.47M | |
| 43.63M | $76.05M | |
| -8613546.00 | $48.35M | |
| -70842795.00 | $76.52M | |
| 19.58M | $48.79M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Lite Strategy, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Lite Strategy, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is Lite Strategy, Inc.'s Enterprise Value?
What is the highest Enterprise Value for Lite Strategy, Inc. (LITS)?
What is the 3-year average Enterprise Value for Lite Strategy, Inc. (LITS)?
What is the 5-year average Enterprise Value for Lite Strategy, Inc. (LITS)?
How does the current Enterprise Value for Lite Strategy, Inc. (LITS) compare to its historical average?